We are live on ! Find out more
NH

NantHealth, Inc

Delisted

NH was delisted on the 23rd of May, 2023.

31 hedge funds and large institutions have $2.27M invested in NantHealth, Inc in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more capital invested

Capital invested by funds: $1.94M → $2.27M (+$324K)

14% less funds holding

Funds holding: 3631 (-5)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

50% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 10

Holders
31
Holders Change
-5
Holders Change %
-13.89%
% of All Funds
0.68%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
10
Closed
10
Calls
Puts
Net Calls
Net Calls Change

NH Hedge Fund Activity: Q3 2019 in Review

31 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q3 2019, worth a combined $2.27M — up 17% from $1.94M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of NH and 5 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 5 added.

The largest buyer was Vanguard Group, adding an estimated $231K. The largest seller was Highbridge Capital Management, cutting an estimated $246K.

  • 31 institutional investors held NantHealth, Inc (NH) as of Q3 2019, down from 36 in Q2 2019.
  • Funds reported $2.27M of NantHealth, Inc stock for Q3 2019, up 17% quarter-over-quarter.
  • 5 funds opened new NantHealth, Inc positions in Q3 2019 and 10 closed out, a net change of -5 holders.
  • The largest NantHealth, Inc buyer in Q3 2019 was Vanguard Group, an estimated $231K added.
  • The largest NantHealth, Inc seller in Q3 2019 was Highbridge Capital Management, an estimated $246K sold.

Based on aggregated 13F filings for Q3 2019.